Healthy men test new cancer drug copycat
NCT ID NCT07299955
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study tests a new drug called Bmab3000, which is similar to an approved breast cancer drug (Herceptin Hylecta). It involves 150 healthy men aged 18-65 who receive a single injection of either the new or the approved drug. The goal is to compare how the body processes each drug, their safety, and any immune reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research (NZCR)
RECRUITINGChristchurch, Main Building: 264 Antigua Street,, New Zealand
Contact
Conditions
Explore the condition pages connected to this study.